论文部分内容阅读
目的:探讨阿托品和复方托品卡胺在青少年散瞳验光中的实用价值。方法:对青少年屈光不正患者92例,按年龄分为Ⅰ组38例(远视20例,近视18例),Ⅱ组54例(远视16例,近视38例),对两组患者均行复方托品卡胺和1%阿托品散瞳后,对其验光结果进行对照观察。结果:Ⅰ组两种药物在近视患者中符合率为88.88%,在远视患者中符合率10%;Ⅱ组中两种药物在近视患者中符合率为92.11%,在远视患者中符合率25%。结论:对于3~8岁远视患者,阿托品散瞳验光较复方托品卡胺准确;9~16岁远视患者仍首选阿托品散瞳,特殊情况下可以用复方托品卡胺替代;3~16岁近视患者可用复方托品卡胺替代阿托品散瞳验光。
Objective: To investigate the practical value of atropine and compound tropicamide in mydriasis optometry in adolescents. Methods: 92 cases of adolescent ametropia, according to age group Ⅰ 38 cases (20 cases of hyperopia, myopia 18 cases), Ⅱ group of 54 cases (hyperopia in 16 cases, 38 cases of myopia), the two groups of patients underwent compound Tropikamid and 1% atropine mydriasis, the results of their optometry were observed. Results: The coincidence rate of two drugs in group I was 88.88% in myopia patients and 10% in hyperopia patients. The coincidence rate of two drugs in group Ⅱ was 92.11% in patients with myopia and 25% in patients with hyperopia . Conclusion: Atropine mydriasis optometry is more accurate than the compound tropicamide for 3 ~ 8 years old hyperopia patients; atropine mydriasis is still the first choice for 9 ~ 16 years old hyperopia patients; in the special case, the compound tropicamide can be replaced; 3 ~ 16 years old Patients with myopia can be used to replace atropine compound tropicamide mydriasis optometry.